• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高级别恶性胶质瘤和弥漫性脑桥内生性胶质瘤患儿的继发性播散

Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas.

作者信息

Wagner S, Benesch M, Berthold F, Gnekow A K, Rutkowski S, Sträter R, Warmuth-Metz M, Kortmann R-D, Pietsch T, Wolff J E A

机构信息

Department of Pediatric Hematology and Oncology, Klinik St Hedwig, University of Regensburg, Regensburg, Germany.

出版信息

Br J Cancer. 2006 Oct 23;95(8):991-7. doi: 10.1038/sj.bjc.6603402. Epub 2006 Oct 3.

DOI:10.1038/sj.bjc.6603402
PMID:17047647
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2360717/
Abstract

In children, treatment regimen for high-grade gliomas (HGG) and diffuse intrinsic pontine gliomas (DIPG) are generally not stratified according to disease stage. The hypothesis was that secondary disseminating disease (SDD) in children with HGG is related to an even worse outcome. Description of SDD pattern was performed. In total, 270 children with newly diagnosed HGG or DIPG were eligible for retrospective analysis of SDD. Medical and computer records of these patients were reviewed for demographic characteristics, sites of dissemination, prognostic variables. Forty-six (17%) of the 270 patients had developed SDD. The median time to SDD was 8.2 months. The median overall survival (OS) after dissemination was 3.2 months. The SDD was located parenchymal in the supratentorial (34.8%), infratentorial (6.5%), supratentorial and infratentorial (19.6%), spinal (10.9%), spinal and cerebral (6.5%) regions of the CNS, or leptomeningeal (21.7%). For HGG patients, the median OS was shorter among patients with SDD than among patients without SDD (1.02 vs 1.41 years, P=0.0495). In the group of patients with SDD, patients with cerebrospinal fluid dissemination had a worse outcome compared with patients with parenchymal metastases. Summarising, SDD is a negative prognostic factor for patients with HGG outside the pons. Treatment stratification should be considered.

摘要

在儿童中,高级别胶质瘤(HGG)和弥漫性脑桥内在胶质瘤(DIPG)的治疗方案通常不会根据疾病阶段进行分层。研究假设是,HGG患儿的继发性播散性疾病(SDD)与更差的预后相关。对SDD模式进行了描述。共有270例新诊断为HGG或DIPG的儿童符合SDD回顾性分析的条件。对这些患者的医疗和计算机记录进行了审查,以了解人口统计学特征、播散部位、预后变量。270例患者中有46例(17%)发生了SDD。发生SDD的中位时间为8.2个月。播散后的中位总生存期(OS)为3.2个月。SDD位于中枢神经系统幕上实质(34.8%)、幕下(6.5%)、幕上和幕下(19.6%)、脊髓(10.9%)、脊髓和脑(6.5%)区域或软脑膜(21.7%)。对于HGG患者,发生SDD的患者中位OS短于未发生SDD的患者(1.02年对1.41年,P=0.0495)。在SDD患者组中,脑脊液播散的患者与实质转移患者相比预后更差。总之,SDD是脑桥外HGG患者的不良预后因素。应考虑治疗分层。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e71/2360717/a6fe35641937/95-6603402f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e71/2360717/05db33e1050f/95-6603402f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e71/2360717/a6fe35641937/95-6603402f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e71/2360717/05db33e1050f/95-6603402f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e71/2360717/a6fe35641937/95-6603402f2.jpg

相似文献

1
Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas.高级别恶性胶质瘤和弥漫性脑桥内生性胶质瘤患儿的继发性播散
Br J Cancer. 2006 Oct 23;95(8):991-7. doi: 10.1038/sj.bjc.6603402. Epub 2006 Oct 3.
2
Primary dissemination of high-grade gliomas in children: experiences from four studies of the Pediatric Oncology and Hematology Society of the German Language Group (GPOH).儿童高级别胶质瘤的原发性播散:来自德语区儿科肿瘤与血液学会(GPOH)四项研究的经验
J Neurooncol. 2005 Apr;72(2):179-83. doi: 10.1007/s11060-004-3546-5.
3
Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma.非脑干高级别胶质瘤和弥漫性固有脑桥胶质瘤患儿、青少年及年轻成人中的假性进展
J Neurooncol. 2016 Aug;129(1):109-21. doi: 10.1007/s11060-016-2151-8. Epub 2016 May 14.
4
A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.一项针对新诊断的高级别胶质瘤和弥漫性脑桥内在型胶质瘤患者的基于贝伐单抗治疗的初步研究。
J Neurooncol. 2016 Mar;127(1):53-61. doi: 10.1007/s11060-015-2008-6. Epub 2015 Dec 1.
5
Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas.端粒维持机制在儿童高级别胶质瘤中的预后意义
J Neurooncol. 2014 Mar;117(1):67-76. doi: 10.1007/s11060-014-1374-9. Epub 2014 Jan 30.
6
Post-radiotherapy apparent diffusion coefficient (ADC) in children and young adults with high-grade gliomas and diffuse intrinsic pontine gliomas.患有高级别胶质瘤和弥漫性脑桥内在胶质瘤的儿童和青年放疗后的表观扩散系数(ADC)
Pediatr Hematol Oncol. 2019 Mar;36(2):103-112. doi: 10.1080/08880018.2019.1592267. Epub 2019 Apr 12.
7
A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma.一项关于丙戊酸和放疗,继以丙戊酸和贝伐珠单抗维持治疗用于新诊断的弥漫性内在脑桥胶质瘤或高级别胶质瘤患儿的 2 期研究。
Pediatr Blood Cancer. 2020 Jun;67(6):e28283. doi: 10.1002/pbc.28283. Epub 2020 Apr 14.
8
Concurrent radiotherapy with temozolomide vs. concurrent radiotherapy with a cisplatinum-based polychemotherapy regimen : Acute toxicity in pediatric high-grade glioma patients.替莫唑胺同步放化疗与顺铂为基础的联合化疗方案同步放化疗治疗儿童高级别胶质瘤患者:急性毒性。
Strahlenther Onkol. 2018 Mar;194(3):215-224. doi: 10.1007/s00066-017-1218-6. Epub 2017 Oct 11.
9
Pediatric diffuse intrinsic pontine glioma patients from a single center.来自单一中心的小儿弥漫性脑桥内在型胶质瘤患者。
Childs Nerv Syst. 2013 Apr;29(4):583-8. doi: 10.1007/s00381-012-1986-3. Epub 2012 Dec 8.
10
Malignant brainstem tumors in children, excluding diffuse intrinsic pontine gliomas.儿童恶性脑干肿瘤,不包括弥漫性固有脑桥胶质瘤。
J Neurosurg Pediatr. 2016 Jan;17(1):57-65. doi: 10.3171/2015.6.PEDS15166. Epub 2015 Oct 16.

引用本文的文献

1
Bone Morphogenic Proteins in Pediatric Diffuse Midline Gliomas: How to Make New Out of Old?骨形态发生蛋白在儿童弥漫性中线脑胶质瘤中的作用:如何变废为宝?
Int J Mol Sci. 2024 Mar 15;25(6):3361. doi: 10.3390/ijms25063361.
2
Advances in Treatment of Diffuse Midline Gliomas.弥漫性中线胶质瘤的治疗进展
Curr Neurol Neurosci Rep. 2023 Dec;23(12):849-856. doi: 10.1007/s11910-023-01317-8. Epub 2023 Nov 3.
3
Diffuse midline glioma invasion and metastasis rely on cell-autonomous signaling.弥漫性中线胶质瘤的侵袭和转移依赖于细胞自主信号。

本文引用的文献

1
Treatment options in childhood pontine gliomas.儿童脑桥胶质瘤的治疗选择。
J Neurooncol. 2006 Sep;79(3):281-7. doi: 10.1007/s11060-006-9133-1. Epub 2006 Apr 6.
2
High-dose methotrexate prior to simultaneous radiochemotherapy in children with malignant high-grade gliomas.高剂量甲氨蝶呤用于恶性高级别胶质瘤患儿同步放化疗之前。
Anticancer Res. 2005 May-Jun;25(3c):2583-7.
3
Primary dissemination of high-grade gliomas in children: experiences from four studies of the Pediatric Oncology and Hematology Society of the German Language Group (GPOH).
Neuro Oncol. 2024 Mar 4;26(3):553-568. doi: 10.1093/neuonc/noad161.
4
Leptomeningeal dissemination in pediatric brain tumors.小儿脑瘤的软脑膜播散。
Neoplasia. 2023 May;39:100898. doi: 10.1016/j.neo.2023.100898. Epub 2023 Apr 1.
5
Pediatric diffuse midline glioma H3K27- altered: A complex clinical and biological landscape behind a neatly defined tumor type.H3K27改变的小儿弥漫性中线胶质瘤:一种定义明确的肿瘤类型背后复杂的临床和生物学情况。
Front Oncol. 2023 Jan 16;12:1082062. doi: 10.3389/fonc.2022.1082062. eCollection 2022.
6
Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle.小儿弥漫性中线胶质瘤:一个未完成的谜题。
Diagnostics (Basel). 2022 Aug 25;12(9):2064. doi: 10.3390/diagnostics12092064.
7
How ten-years of reirradiation for paediatric high-grade glioma may shed light on first line treatment.小儿高级别胶质瘤十年再照射如何为一线治疗提供线索。
J Neurooncol. 2022 Sep;159(2):437-445. doi: 10.1007/s11060-022-04079-4. Epub 2022 Jul 9.
8
Leptomeningeal disease and tumor dissemination in a murine diffuse intrinsic pontine glioma model: implications for the study of the tumor-cerebrospinal fluid-ependymal microenvironment.小鼠弥漫性脑桥内在型胶质瘤模型中的软脑膜疾病和肿瘤播散:对肿瘤-脑脊液-室管膜微环境研究的启示
Neurooncol Adv. 2022 Apr 26;4(1):vdac059. doi: 10.1093/noajnl/vdac059. eCollection 2022 Jan-Dec.
9
A novel mouse model of diffuse midline glioma initiated in neonatal oligodendrocyte progenitor cells highlights cell-of-origin dependent effects of H3K27M.一种在新生少突胶质细胞祖细胞中引发的弥漫性中线胶质瘤的新型小鼠模型突出了H3K27M的细胞起源依赖性效应。
Glia. 2022 Sep;70(9):1681-1698. doi: 10.1002/glia.24189. Epub 2022 May 7.
10
Disseminated diffuse midline glioma associated with poorly differentiated orbital lesion and metastases in an 8-year-old girl: case report and literature review.8 岁女孩伴弥散中线胶质瘤、未分化眶内病变及转移:病例报告及文献复习。
Childs Nerv Syst. 2022 Oct;38(10):2005-2010. doi: 10.1007/s00381-022-05530-7. Epub 2022 Apr 23.
儿童高级别胶质瘤的原发性播散:来自德语区儿科肿瘤与血液学会(GPOH)四项研究的经验
J Neurooncol. 2005 Apr;72(2):179-83. doi: 10.1007/s11060-004-3546-5.
4
Oral topotecan in children with recurrent or progressive high-grade glioma: a Phase I/II study by the German Society for Pediatric Oncology and Hematology.口服拓扑替康治疗复发或进展性高级别胶质瘤儿童:德国儿科肿瘤学和血液学协会的一项I/II期研究
Cancer. 2004 Apr 15;100(8):1750-7. doi: 10.1002/cncr.20168.
5
Leptomeningeal dissemination of cerebellar malignant astrocytomas.小脑恶性星形细胞瘤的软脑膜播散
J Neurooncol. 2003 Jun;63(2):191-9. doi: 10.1023/a:1023983518341.
6
Symptomatic spinal dissemination of malignant astrocytoma.恶性星形细胞瘤的症状性脊髓播散
J Neurooncol. 2003 Feb;61(3):227-35. doi: 10.1023/a:1022536828345.
7
Simultaneous radiochemotherapy in pediatric patients with high-grade glioma: a phase I study.小儿高级别胶质瘤同步放化疗:一项I期研究
Anticancer Res. 2002 Nov-Dec;22(6B):3569-72.
8
Treatment of paediatric pontine glioma with oral trophosphamide and etoposide.口服环磷酰胺和依托泊苷治疗儿童桥脑胶质瘤。
Br J Cancer. 2002 Oct 21;87(9):945-9. doi: 10.1038/sj.bjc.6600552.
9
Preradiation chemotherapy for pediatric patients with high-grade glioma.小儿高级别胶质瘤患者的放疗前化疗
Cancer. 2002 Jan 1;94(1):264-71. doi: 10.1002/cncr.10114.
10
Oral trofosfamide and etoposide in pediatric patients with glioblastoma multiforme.口服曲磷酰胺和依托泊苷用于多形性胶质母细胞瘤儿科患者的研究
Cancer. 2000 Nov 15;89(10):2131-7. doi: 10.1002/1097-0142(20001115)89:10<2131::aid-cncr14>3.0.co;2-j.